Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report

Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.13246
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 Mg in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

AB034. Muscular Metastasis From Non-Small Cell Lung Cancer: A Case Report

Annals of Translational Medicine
Medicine
2016English

Targeting HER2 Aberrations in Non-Small Cell Lung Cancer With Osimertinib

Clinical Cancer Research
Cancer ResearchOncology
2018English

Intradural Extramedullary Metastasis of Small Cell Lung Cancer: A Case Report

Korean Journal of Spine
2012English

Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer

PLoS ONE
Multidisciplinary
2009English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

Management of Leptomeningeal Metastases in Non-Oncogene Addicted Non-Small Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

P2.01-29 Economic Analysis of Osimertinib in Previously Untreated EGFR-Positive Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Modality of Resistance and Subsequent Management of Patients With Advanced Non-Small Cell Lung Cancer Failing Treatment With Osimertinib

Targeted Oncology
Cancer ResearchOncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy